Key Highlights:
- Zydus Lifesciences launched Aerolife Mini, a next-gen pMDI enhancer, marking a push into drug-device innovation in respiratory care; notably, it is India’s first portable, foldable spacer, introduced under an exclusive licensing deal with AeroDel.
- With rising cases of asthma, COPD, and bronchiectasis, effective drug delivery remains a challenge, especially as ~94% of patients use inhalers incorrectly, reducing treatment benefits. While spacers help, existing options are often bulky and inconvenient, limiting real-world adherence.
- Aerolife Mini addresses this gap with a compact, foldable, ready-to-use design, improving drug deposition, ease of use, and patient compliance, supporting Zydus’ strategy to build patient-centric, differentiated respiratory solutions.
Implications:
Aerolife Mini strengthens Zydus’ differentiation in a crowded inhaled therapy market by adding a simple, device-based solution that directly tackles poor inhaler technique.
By offering a compact, foldable spacer that patients are more likely to carry and use, Zydus can improve real-world outcomes for its own respiratory brands and deepen loyalty among pulmonologists and GPs who prioritize correct drug delivery.
Source: Express Pharma
